Elevance Health, Inc. (ELV)
Pre-market:
| Previous close | 525.61 |
| Open | 525.28 |
| Bid | 0.00 x 800 |
| Ask | 837.86 x 800 |
| Day's range | 518.90 - 528.33 |
| 52-week range | 412.00 - 542.07 |
| Volume | |
| Avg. volume | 979,208 |
| Market cap | 122.475B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 19.88 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.52 (1.24%) |
| Ex-dividend date | 10 Jun 2024 |
| 1y target est | N/A |
- Business Wire
Elevance Health Reports First Quarter 2024 Results
INDIANAPOLIS, April 18, 2024--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2024 results.
- Business Wire
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
INDIANAPOLIS, April 15, 2024--Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes. This effort, which will operate across multiple regions of the United States, will bring together certain care delivery and enablement assets of Elevance Health’s Carelon Health and CD&R portfolio companies, apree health and Mille
- Business Wire
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
INDIANAPOLIS, April 03, 2024--Elevance Health (NYSE: ELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
